Treatment of advanced gastric cancer with cetuximab plus chemotherapy followed by surgery. Report of a case

Riccardo Casadei, Daniela Rega, Carmine Pinto, Francesco Monari, Claudio Ricci, Gianluca Sciannamea, Francesco Minni

Research output: Contribution to journalArticle

Abstract

The prognosis of patients affected by advanced gastric cancer who did not undergo non-curative resection is extremely poor. We report a case of a 26-year-old woman affected by gastric cancer with peritoneal carcinosis in whom surgical treatment was not considered. The patient was enrolled in the Italian phase II trial of cetuximab (Erbitux, Merck KGaA, Darmstadt, Germany), a monoclonal antibody, in combination with docetaxel and cisplatin chemotherapy. Restaging of the tumor showed progressive regression, so the patient underwent a total gastrectomy. The patient is alive, well and disease-free ten months after surgery. The good result achieved in this patient provides interesting prospects for chemotherapy combined with cetuximab, followed by surgery.

Original languageEnglish
Pages (from-to)811-814
Number of pages4
JournalTumori
Volume95
Issue number6
Publication statusPublished - Nov 2009

Fingerprint

Stomach Neoplasms
Drug Therapy
docetaxel
Therapeutics
Gastrectomy
Cisplatin
Germany
Monoclonal Antibodies
Cetuximab
Neoplasms

Keywords

  • Cetuximab
  • Gastrectomy
  • Gastric cancer
  • Neoadjuvant therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Casadei, R., Rega, D., Pinto, C., Monari, F., Ricci, C., Sciannamea, G., & Minni, F. (2009). Treatment of advanced gastric cancer with cetuximab plus chemotherapy followed by surgery. Report of a case. Tumori, 95(6), 811-814.

Treatment of advanced gastric cancer with cetuximab plus chemotherapy followed by surgery. Report of a case. / Casadei, Riccardo; Rega, Daniela; Pinto, Carmine; Monari, Francesco; Ricci, Claudio; Sciannamea, Gianluca; Minni, Francesco.

In: Tumori, Vol. 95, No. 6, 11.2009, p. 811-814.

Research output: Contribution to journalArticle

Casadei, R, Rega, D, Pinto, C, Monari, F, Ricci, C, Sciannamea, G & Minni, F 2009, 'Treatment of advanced gastric cancer with cetuximab plus chemotherapy followed by surgery. Report of a case', Tumori, vol. 95, no. 6, pp. 811-814.
Casadei R, Rega D, Pinto C, Monari F, Ricci C, Sciannamea G et al. Treatment of advanced gastric cancer with cetuximab plus chemotherapy followed by surgery. Report of a case. Tumori. 2009 Nov;95(6):811-814.
Casadei, Riccardo ; Rega, Daniela ; Pinto, Carmine ; Monari, Francesco ; Ricci, Claudio ; Sciannamea, Gianluca ; Minni, Francesco. / Treatment of advanced gastric cancer with cetuximab plus chemotherapy followed by surgery. Report of a case. In: Tumori. 2009 ; Vol. 95, No. 6. pp. 811-814.
@article{069647255fd64c42b0ebf4c645678fa1,
title = "Treatment of advanced gastric cancer with cetuximab plus chemotherapy followed by surgery. Report of a case",
abstract = "The prognosis of patients affected by advanced gastric cancer who did not undergo non-curative resection is extremely poor. We report a case of a 26-year-old woman affected by gastric cancer with peritoneal carcinosis in whom surgical treatment was not considered. The patient was enrolled in the Italian phase II trial of cetuximab (Erbitux, Merck KGaA, Darmstadt, Germany), a monoclonal antibody, in combination with docetaxel and cisplatin chemotherapy. Restaging of the tumor showed progressive regression, so the patient underwent a total gastrectomy. The patient is alive, well and disease-free ten months after surgery. The good result achieved in this patient provides interesting prospects for chemotherapy combined with cetuximab, followed by surgery.",
keywords = "Cetuximab, Gastrectomy, Gastric cancer, Neoadjuvant therapy",
author = "Riccardo Casadei and Daniela Rega and Carmine Pinto and Francesco Monari and Claudio Ricci and Gianluca Sciannamea and Francesco Minni",
year = "2009",
month = "11",
language = "English",
volume = "95",
pages = "811--814",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "6",

}

TY - JOUR

T1 - Treatment of advanced gastric cancer with cetuximab plus chemotherapy followed by surgery. Report of a case

AU - Casadei, Riccardo

AU - Rega, Daniela

AU - Pinto, Carmine

AU - Monari, Francesco

AU - Ricci, Claudio

AU - Sciannamea, Gianluca

AU - Minni, Francesco

PY - 2009/11

Y1 - 2009/11

N2 - The prognosis of patients affected by advanced gastric cancer who did not undergo non-curative resection is extremely poor. We report a case of a 26-year-old woman affected by gastric cancer with peritoneal carcinosis in whom surgical treatment was not considered. The patient was enrolled in the Italian phase II trial of cetuximab (Erbitux, Merck KGaA, Darmstadt, Germany), a monoclonal antibody, in combination with docetaxel and cisplatin chemotherapy. Restaging of the tumor showed progressive regression, so the patient underwent a total gastrectomy. The patient is alive, well and disease-free ten months after surgery. The good result achieved in this patient provides interesting prospects for chemotherapy combined with cetuximab, followed by surgery.

AB - The prognosis of patients affected by advanced gastric cancer who did not undergo non-curative resection is extremely poor. We report a case of a 26-year-old woman affected by gastric cancer with peritoneal carcinosis in whom surgical treatment was not considered. The patient was enrolled in the Italian phase II trial of cetuximab (Erbitux, Merck KGaA, Darmstadt, Germany), a monoclonal antibody, in combination with docetaxel and cisplatin chemotherapy. Restaging of the tumor showed progressive regression, so the patient underwent a total gastrectomy. The patient is alive, well and disease-free ten months after surgery. The good result achieved in this patient provides interesting prospects for chemotherapy combined with cetuximab, followed by surgery.

KW - Cetuximab

KW - Gastrectomy

KW - Gastric cancer

KW - Neoadjuvant therapy

UR - http://www.scopus.com/inward/record.url?scp=76349112049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76349112049&partnerID=8YFLogxK

M3 - Article

C2 - 20210249

AN - SCOPUS:76349112049

VL - 95

SP - 811

EP - 814

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 6

ER -